Now, both the Pfizer and the Moderna booster shots can be given five months after the second dose of vaccine — down from six months.
The Food and Drug Administration greenlights the biotech firm's vaccine for emergency use in the U.S. The move bolsters a vast inoculation effort that's already underway.
The Food and Drug Administration says is advising health workers to use "every full dose obtainable" to help speed up the nationwide immunization campaign.
Pfizer and BioNTech's vaccine is the first to receive an emergency authorization from the Food and Drug Administration. Officials say it may be ready for widespread inoculations within days.
The Food and Drug Administration's authorization of a COVID-19 vaccine could come in a day or two, a member of an FDA expert panel says. But he says it may be late 2021 before normalcy returns.
The pharmaceutical giant and partner BioNTech announced Friday that they are submitting a formal request to the Food and Drug Administration, just days after the vaccine was shown to be 95% effective.
The Federal Trade Commission issued warning letters to several companies that marketed an unproven drug to treat COVID-19. Sales of the nonapproved drug, thymosin alpha-1, were first reported by NPR.
An NPR investigation revealed a network of doctors marketing a non-FDA approved drug as a purported treatment for COVID-19. Now, Rep. Raja Krishnamoorthi (D-Ill.) is calling for federal enforcement.
Friday on Political Rewind: The Centers for Disease Control and Prevention (CDC) has been the gold standard of global public health organizations for many decades. But recent efforts to marginalize and undermine such trusted public health agencies — including the U.S. Food and Drug Administration (FDA) — are complicating the COVID-19 response.
How does this affect Americans' perceptions and the country's ability to combat coronavirus, particularly when a vaccine does become available? We discuss the politicization of a pandemic.
The Food and Drug Administration's chief said Sunday the therapy reduces deaths among COVID-19 patients by 35%. On Monday he apologized, acknowledging that statistic greatly exaggerates any benefit.